FMT

FMT

2901 bookmarks
Custom sorting
Current and Emerging Applications of Fecal Microbiota Transplantation - PubMed
Current and Emerging Applications of Fecal Microbiota Transplantation - PubMed
Fecal microbiota transplantation (FMT) is a life-changing treatment for people with recurrent Clostridioides difficile infection (rCDI). Frequently acquired in the hospital, CDI can cause serious gastrointestinal symptoms, including persistent watery diarrhea, abdominal pain, and severe dehydration. …
·pubmed.ncbi.nlm.nih.gov·
Current and Emerging Applications of Fecal Microbiota Transplantation - PubMed
Targeting The Gut–Brain Axis With Live Biotherapeutic Products
Targeting The Gut–Brain Axis With Live Biotherapeutic Products
Treating seizures with bacteria — Bloom Science's CEO, Dr. Christopher Reyes, explains how his company aims to leverage the gut–brain axis using live biotherapeutic products (LBP).
·news.google.com·
Targeting The Gut–Brain Axis With Live Biotherapeutic Products
Washed microbiota transplantation for Clostridioides difficile infection: a national multi-center real-world study - PubMed
Washed microbiota transplantation for Clostridioides difficile infection: a national multi-center real-world study - PubMed
This study emphasizes the attractive value of WMT for CDI. Early WMT might be a recommendation for CDI, especially for those in serious condition or with complex comorbidities for decreasing deterioration, medical costs, and pain. This article is protected by copyright. All rights reserved.
·pubmed.ncbi.nlm.nih.gov·
Washed microbiota transplantation for Clostridioides difficile infection: a national multi-center real-world study - PubMed
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations - PubMed
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations - PubMed
Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic dysfunction for which effective interventions are lacking. To investigate the effects of resistant starch (RS) as a microbiota-directed dietary supplement for NAFLD treatment, we coupled a 4-month randomized placebo-co …
·pubmed.ncbi.nlm.nih.gov·
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations - PubMed
Transformation of colitis and colorectal cancer: a tale of gut microbiota - PubMed
Transformation of colitis and colorectal cancer: a tale of gut microbiota - PubMed
Intestinal inflammation modifies host physiology to promote the occurrence of colorectal cancer (CRC), as seen in colitis-associated CRC. Gut microbiota is crucial in cancer progression, primarily by inducing intestinal chronic inflammatory microenvironment, leading to DNA damage, chromosomal mutati …
·pubmed.ncbi.nlm.nih.gov·
Transformation of colitis and colorectal cancer: a tale of gut microbiota - PubMed
Fecal Microbiota Transplantation-Mediated Ghrelin Restoration Improves Neurological Functions After Traumatic Brain Injury: Evidence from 16S rRNA Sequencing and In Vivo Studies - PubMed
Fecal Microbiota Transplantation-Mediated Ghrelin Restoration Improves Neurological Functions After Traumatic Brain Injury: Evidence from 16S rRNA Sequencing and In Vivo Studies - PubMed
This study aimed to investigate how gut microbiota dysbiosis impacts the repair of the blood-brain barrier and neurological deficits following traumatic brain injury (TBI). Through 16S rRNA sequencing analysis, we compared the gut microbiota of TBI rats and normal controls, discovering significant d …
·pubmed.ncbi.nlm.nih.gov·
Fecal Microbiota Transplantation-Mediated Ghrelin Restoration Improves Neurological Functions After Traumatic Brain Injury: Evidence from 16S rRNA Sequencing and In Vivo Studies - PubMed
Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea - PubMed
Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea - PubMed
FMT performed twice at an interval of four weeks did not significantly reduce IBS-SSS score. However, more patients had improvement in abdominal bloating, which was associated with a reduction in hydrogen sulphide-producing bacteria. (ClinicalTrials.gov NCT03125564).
·pubmed.ncbi.nlm.nih.gov·
Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea - PubMed
Retraction statement: Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats - PubMed
Retraction statement: Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats - PubMed
Toral, M, Robles-Vera, I, de la Visitación, N, et al. Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats. Acta Physiol. 2019; 227:e13285. https://doi.org/10.1111/apha.13285. The above article, published online on April 20, 2 …
·pubmed.ncbi.nlm.nih.gov·
Retraction statement: Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats - PubMed
Fecal microbiota transplantation in a child with severe ASD comorbidities of gastrointestinal dysfunctions-a case report - PubMed
Fecal microbiota transplantation in a child with severe ASD comorbidities of gastrointestinal dysfunctions-a case report - PubMed
Autism spectrum disorder (ASD) is a neurodevelopmental disorder defined by social communication impairments and restricted, repetitive behaviors. In addition to behavioral interventions and psychotherapies, and pharmacological interventions, in-depth studies of intestinal microbiota in ASD has obvio …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation in a child with severe ASD comorbidities of gastrointestinal dysfunctions-a case report - PubMed
Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway - PubMed
Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway - PubMed
FMT may ameliorate DSS-induced colitis by regulating the TLR4 signaling pathway. TLR4 modulates the composition of gut microbiota and the expression of related genes to ameliorate colitis and maintain the stability of the intestinal environment. Akkermansia bear great therapeutic potential fo …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway - PubMed
In vitro ruminal fermentation and cow-to-mouse fecal transplantations verify the inter-relationship of microbiome and metabolome biomarkers: potential to promote health in dairy cows - PubMed
In vitro ruminal fermentation and cow-to-mouse fecal transplantations verify the inter-relationship of microbiome and metabolome biomarkers: potential to promote health in dairy cows - PubMed
We provided evidence that the bacterial biomarkers alter downstream metabolites. This could indirectly indicate that the two bacterial biomarkers have the potential to be used as next-generation probiotics for dairy cattle, although it needs more evidence to support our hypothesis. Two species, iR/i …
·pubmed.ncbi.nlm.nih.gov·
In vitro ruminal fermentation and cow-to-mouse fecal transplantations verify the inter-relationship of microbiome and metabolome biomarkers: potential to promote health in dairy cows - PubMed
Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis - PubMed
Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis - PubMed
To explore the efficacy and safety of fecal microbiota transplantation (FMT) as a treatment approach for ulcerative colitis (UC), a comprehensive systematic review and meta-analysis of randomized controlled trials was conducted. To collect and evaluate randomized controlled trials of high quality on …
·pubmed.ncbi.nlm.nih.gov·
Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis - PubMed
Microbiome Therapeutics Market 2023 Key Factors - Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon
Microbiome Therapeutics Market 2023 Key Factors - Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon
Global Microbiome Therapeutics Market is a professional market research study conducted by MarketsandResearch biz covering market growth prospects and potential The study provides an overview of the industry covering the market synopsis specifications product description and objectives The first portion ...
·news.google.com·
Microbiome Therapeutics Market 2023 Key Factors - Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon
Europe Human Microbiome Market is growing with a CAGR of 19.9% by 2029
Europe Human Microbiome Market is growing with a CAGR of 19.9% by 2029
Microbiome is the genetic material of all the microbes bacteria fungi protozoa and viruses that live on and inside the human body The number of genes in all the microbes in one person s microbiome is 200 times the number ...
·news.google.com·
Europe Human Microbiome Market is growing with a CAGR of 19.9% by 2029
What to Know About Fecal Transplant for Ulcerative Colitis
What to Know About Fecal Transplant for Ulcerative Colitis
Research into using a fecal transplant for ulcerative colitis is in its early stages. Learn more about how it works, and possible benefits and risks.
·news.google.com·
What to Know About Fecal Transplant for Ulcerative Colitis
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease - PubMed
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease - PubMed
Children with IBD have an elevated incidence of CDI, but their CDI risk does not associate with established risk factors in adults with IBD. Existing testing methodologies are inadequate at differentiating CDI from C. difficile colonization in children with IBD. Fecal microbiota transplantation offe …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease - PubMed
Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study - PubMed
Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study - PubMed
Whether the alternated microbiota in the gut contribute to the risk of allograft rejection (AR) and pulmonary infection (PI) in the setting of lung transplant recipients (LTRs) remains unexplored. A prospective multicenter cohort of LTRs was identified in the four lung transplant centers. Paired fec …
·pubmed.ncbi.nlm.nih.gov·
Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study - PubMed
Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile - PubMed
Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile - PubMed
Due to suppressive antibiotics, patients with recurrent Clostridium difficile have gut microbial communities that are devoid of most commensal microbes. Studies have shown that most of the failures using fecal microbe transplantation (FMT) for recurrent C. difficile occur during the first 4 weeks fo …
·pubmed.ncbi.nlm.nih.gov·
Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile - PubMed
Patient perception of rectal delivery of LBP for rCDI | PPA
Patient perception of rectal delivery of LBP for rCDI | PPA
Ascertaining patient perception of route of rectal administration of live biotherapeutic product (LBP) for recurrent Clostridioides difficile infection (rCDI)
·news.google.com·
Patient perception of rectal delivery of LBP for rCDI | PPA
Burden of C. Difficile and Novel Therapies
Burden of C. Difficile and Novel Therapies
Risks for sepsis and colectomy during the first twelve months of C. Difficile as well as additional burdens on the healthcare system. Novel therapies are also discussed.
·news.google.com·
Burden of C. Difficile and Novel Therapies
GutMicrobiota Health on X
GutMicrobiota Health on X
In Germany, FMT is used less frequently than in the European comparison. One application hurdle is the regulatory classification of FMT as a non-approved drug, which leads to higher costs in manufacturing and makes reimbursement difficult: https://t.co/FmPHWbFkI3
·twitter.com·
GutMicrobiota Health on X